Information Provided By: 
Fly News Breaks for April 12, 2017
SYK
Apr 12, 2017 | 06:50 EDT
Piper Jaffray analyst Matt O'Brien raised his price target for Stryker to $148 telling investors to pay more attention to the neurovascular business than MAKO. He believes the business will drive "considerable, high margin growth for several years." Following a deep dive analysis, O'Brien says he remains "cautiously constructive" on Stryker. The analyst keeps an Overweight rating on the name.
News For SYK From the Last 2 Days
There are no results for your query SYK
